Featured Research

from universities, journals, and other organizations

Single-dose H1N1 vaccine not reliable protection for pediatric liver transplant patients

Date:
July 26, 2011
Source:
Wiley-Blackwell
Summary:
Researchers from Australia determined that pediatric liver transplant patients who received a single-dose of the H1N1 vaccine were not adequately protected against the virus compared to healthy children. This study found that a second vaccination was needed to elicit an effective immune response in children 10 and older who had recently received a liver transplant.

Researchers from Australia determined that pediatric liver transplant patients who received a single-dose of the H1N1 vaccine were not adequately protected against the virus compared to healthy children. This study appearing in the August issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, found that a second vaccination was needed to elicit an effective immune response in children 10 and older who had recently received a liver transplant.

In April 2009 a novel strain of H1N1 influenza virus (swine flu) was identified and its rapid spread led to the World Health Organization's (WHO) declaration of a pandemic in June 2009. Epidemiologists quickly determined that children and immunosuppressed patients were particularly susceptible to the virus, with studies finding higher rates of morbidity and mortality compared to seasonal flu. Following positive trial, a single dose of H1N1/09 vaccine was recommended for healthy children (10 and older) and adults. However, medical evidence has shown immunocompromised patients to have lower immune response rates to routine vaccinations.

Given the lack of data pertaining to immune response in liver transplant patients, a research team led by Dr. Wolfram Haller with the Murdoch Childrens Research Institute and Royal Children's Hospital in Melbourne, Australia, recruited 21 pediatric patients (aged 10 and older) who underwent liver transplantation at the facility. The observational study was conducted from November 2009 through October 2010. Participants were given a single dose (15μg) of the H1N1/09 vaccine, with a second dose administered to those children who did not display adequate concentrations of the vaccine to protect against the virus. Blood samples were taken before and >6 weeks following vaccination to measure antibody levels.

Results showed that 62% of subjects produced an adequate increase in antibody titres against the H1N1 virus after the first vaccine dose with the seroconversion rate increasing to 90% with a second follow-up dose. Roughly, 33% of patients had antibodies against the virus (seropositive) at baseline, that is before the vaccination. Out of these, 86% developed antibodies after the initial vaccination. Of the patients without H1N1 antibodies (seronegative) at baseline only half had an immune response after the first vaccination. Researchers determined that increasing time since transplant correlated with successful immune response.

"Our research provides the first evidence of immunogenicity of the H1N1/09 vaccine in pediatric liver transplant patients," said Dr. Haller. Study results showed that the recommended single dose of the H1N1/09 vaccine for children 10 years of age and older did not provide protection for similar aged children who underwent liver transplantation. "Immune response to the H1N1 vaccine in a non-pandemic situation should be investigated and further research is urgently needed to develop new vaccine strategies that protect high-risk patient groups from the H1N1 influenza," Haller concluded.

The Centers for Disease Control and Prevention (CDC) estimate that 43 million to 89 million Americans were infected with H1N1 between April 2009 and April 10, 2010, with approximately 14 million to 28 million of those cases in children 17 years of age and younger. On August 10, 2010 the WHO International Health Regulations Emergency Committee officially declared an end to the 2009 H1N1 pandemic.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wolfram Haller, Jim Buttery, Karen Laurie, Kathe Beyerle, Winita Hardikar, George Alex. lmmune response to pandemic influenza a (pH1N1/09) vaccination in pediatric liver transplant recipients. Liver Transplantation, 2011; DOI: 10.1002/lt.22283

Cite This Page:

Wiley-Blackwell. "Single-dose H1N1 vaccine not reliable protection for pediatric liver transplant patients." ScienceDaily. ScienceDaily, 26 July 2011. <www.sciencedaily.com/releases/2011/07/110726093149.htm>.
Wiley-Blackwell. (2011, July 26). Single-dose H1N1 vaccine not reliable protection for pediatric liver transplant patients. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2011/07/110726093149.htm
Wiley-Blackwell. "Single-dose H1N1 vaccine not reliable protection for pediatric liver transplant patients." ScienceDaily. www.sciencedaily.com/releases/2011/07/110726093149.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins